Abstract:Objective:To investigate the proportion of patients with clinical remission and sustained remission in Chinses patients with rheumatoid arthritis (RA).Methods:We retrospectively reviewed the medical records of RA patients in our center from January 1, 2011 to December 31, 2016. Disease activity scores and remission status at each visit were assessed by the disease activity score in 28 joints (DAS28), the simplified disease activity index (SDAI), the clinical disease activity index (CDAI), and the American Ccollege of Rheumatology/European league Against Rheumatism (ACR/EULAR) Boolean criteria. Patients were considered in sustained remission if they maintained remission during consecutive visits for 6 months. Kaplan-Meier method was applied to plot cumulative possibility of achieving remission and calculate the median time to first clinical remission. Cox multivariate regression analysis was used to analyze the relative factors of sustained remission.Results:A total of 648 patients were included in the present study. During the median follow-up of 24 months, around 70% of patients reached clinical remission at least once (DAS28: 78.7%, SDAI: 70.8%, CDAI: 68.4%, Boolean criteria: 68.7%). Specifically, the cumulative probability of achieving remission at 3-, 6- and 12- month was 10.6%-24.4%, 25.3%-43.5% and 51.8%-65.2% respectively, depending on instruments applied. The median time to first remission was 7.2 (DAS28), 10.1(SDAI), 11.7(CDAI), 11.4(Boolean criteria) months. Regarding the sustained remission, nearly half of patients experienced SR defined by DAS28(52.2%), CDAI(46.6%), SDAI(45.1%), and Boolean definitions (43.7%) respectively. Among those patients in sustained remission, the median time of persistence remission during study period was 16.0 months (DAS28-ESR), 15.4 months (CDAI), 14.9 months (SDAI) and 15.0 months (Boolean criteria). Among patients achieving sustained remission, the percentage was 18.7% and 81.3% for DMARD monotherapy and combination therapy, respectively. Additionally, 22.3% of patients received low-dose glucocorticoids treatment concomitantly and over half of them successfully tapered or discontinued the glucocorticoids during the period of sustained remission.Conclusion:In daily practice, clinical remission is a realistic target in the setting of treat-to-target strategy, and over half of patients achieveclinical remission in the first year of follow-up. Among those patients who achieve clinical remission, around half of them reach sustained remission over the subsequent follow-up period. The median time of persistent remission in patients achieving remission is about 15 months.

Patient-reported outcomes in Chinese rheumatoid arthritis patients: a systematic review and meta-analysis

Disability and Health-Related Quality of Life in Chinese Patients with Rheumatoid Arthritis: A Cross-Sectional Study.

The real experience of reporting electronic patient-reported outcomes in patients with inflammatory arthritis and factors influencing participation: a scoping review

Remission Assessment of Rheumatoid Arthritis in Daily Practice in China: a Cross-Sectional Observational Study.

Reliability and validity of patient-reported outcome measures in assessing knee osteoarthritis in the Chinese population: A systematic review

The Effects of Patient Education on Psychological Status and Clinical Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

A cross-sectional study on the application of patient-reported outcome measurements in clinical trials of traditional Chinese medicine in mainland China

The combination of Chinese and Western Medicine in the management of rheumatoid arthritis: A real-world cohort study across China

Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients

Knowledge, attitudes, and practices of dietary management among patients with rheumatoid arthritis in China

[Cross-Sectional Study on Quality of Life and Disease Activity of Rheumatoid Arthritis Patients].

SAT0117 THE IMPACT OF DIFFERENT CRITERIA SETS ON EARLY REMISSION AND IDENTIFYING ITS PREDICTORS IN RHEUMATOID ARTHRITIS: RESULTS FROM AN OBSERVATIONAL COHORT (2009–2018)

The Universal Presence of Poor Prognostic Factors Based on EULAR Recommendations: A Real-World Study in 1164 Chinese RA Patients.

Proportion of Patients with Clinical Remission and Sustained Clinical Remission Measured by Various Validated Indices in Patients with Rheumatoid Arthritis: a Single-Institution Observational Study

The State of Patient-Reported Outcome Measures in Rheumatology

The characteristics and its contributing factors of refractory rheumatoid arthritis, view of the rheumatologists of China: results of a nationwide cross-sectional survey

Clinical Efficacy of Acupuncture for the Treatment of Rheumatoid Arthritis: Meta-Analysis of Randomized Clinical Trials

Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey

Effects of Acupuncture on Rheumatoid Arthritis: a Systematic Review and Meta-Analysis

Reporting and influencing factors of patient-reported outcomes in acupuncture randomised controlled trials: a cross-sectional study protocol

Quality of evidence supporting the role of probiotics for rheumatoid arthritis: an overview of systematic reviews